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A factor generated during the sequential interaction of the first seven of the nine 
components  of  complement  (C')  is  chemotactic for polymorphonuclear  leukocytes 
(1-3). This factor, referred to as C'(5, 6, 7)a, has been identified as the activated tri- 
molecular complex consisting of the fifth (C'5), sixth (C'6), and seventh (Ct?) com- 
ponents of complement. C'(5, 6, 7)a mediates the selective, unidirectional migration 
of polymorphonuclear leukocytes in vitro, and it may also be a mediator in immuno- 
logically induced acute inflammatory reactions involving vascular structures  of the 
skin  (4)  and kidneys  (5).  In addition,  a  complement-assocLuted  chemotactic factor 
can be demonstrated for brief periods of time in the plasma of rabbits following in- 
jection of zymosan (2). 
Organophosphorus  inhibitors  such  as  diisopropylphosphofluoridate  or  p-nitro- 
phenyl  ethyl  phosphonates  are  specific,  irreversible  inhibitors  of  serine  esterases. 
They inhibit the C'(5, 6, 7)a-induced chemotaxis of rabbit polymorphonuclear leuko- 
cytes by two different mechanisms (5, 7). In the first, the leukocytes and organophos- 
phorus inhibitor are incubated together for an appropriate period of time. After being 
washed  free  of inhibitor,  the  leukocytes are  found  to  have  lost  their  chemotactic 
responsiveness.  This  "cell-dependent  inhibition"  is  believed  to  be  caused  by  the 
irreversible  inactivation  by the  organophosphorus inhibitor  of an  esterase  existing 
in or on the cell in an already activated state (6). This so-called "activated  esterase" 
has  a  distinct  affinity for acetate  esters,  suggesting that  it  might be  similar  in  its 
activity to an acetylase or acetyl esterase (7). 
The second method of inhibition is to incubate the organophosphorus compound 
with neutrophils during the chemotactic assay. Under the proper experimental con- 
ditions,  the  resulting  inhibition  is  due  neither  to  an  inactivation  of the  activated 
esterase nor to a direct action on the chemotactic factor. Rather, this so called "chemo- 
tactic factor-dependent inhibition" is the result of inhibition of a second esterase, the 
"activatable esterase." This latter esterase is present in or on the cell in a phospho- 
nate-insusceptible form which is enzymatically inert.  Contact of the leukocyte with 
the chemotactic factor leads to a conversion of the enzyme to an active serine esterase 
that is susceptible  to the inhibitory action of the organophosphorus compound  (6). 
* This work was supported  by the National Institutes of Health,  Bethesda,  Md.; Grant 
AI 07291 AIA. 
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The  serine esterases,  although  a  restricted dass of enzymes,  still comprise very 
many different kinds of esterases. In order to establish the biochemical role of the 
activatable esterase in chemotaxis, it will be necessary to isolate this enzyme in pure 
form.  For this purpose, it is necessary that additional means of characterizing the 
enzyme be available. The furnishing of such possible further identifying character- 
istics for the activatable esterase is in part the subject of this paper. 
Previous observations by one of us (P.A.W.) have indicated that incubation 
for appropriate periods of time of polymorphonuclear leukocytes with prepara- 
tions containing C~(5,  6, 7)a resulted in an irreversible loss in the ability of the 
leukocytes to give a  chemotactic response to Ct(5, 6, 7)a. We have termed the 
specific, irreversible loss of responsiveness induced in this manner  "deactiva- 
tion." The first part of this paper is devoted to showing that deactivation arises 
from the action of C~(5,  6, 7)a on the leukocyte. The second portion will demon- 
strate  that  the phosphonate  esters  prevent  deactivation in  a  manner  which 
indicates  that  the  activatable esterase  is  involved in  deactivation. Lastly it 
will be shown that simple aromatic amino acid derivatives specifically prevent 
deactivation and also inhibit chemotaxis, suggesting that the activatable ester- 
ase is a serine esterase with a particular affinity for compounds containing aro- 
matic amino acids. 
Materials  and Methods ~ 
Chemotaxls.--The  ability of polymorphonuclear  leukocytes  (neutrophils)  to migrate to- 
ward a  concentration gradient of Ct(5,6,7)a  was  measured  by  the use of chambers  with 
micropore  filters.  Rabbit  neutrophils were  obtained from  a  glycogen-induced  peritoneal 
exudate and suspended in 0.5% ovalbumin. Details of these techniques are described  elsewhere 
(2,6). 
Aaivated  Serum.--The  complement-associated  chemotactic factor was generated in fresh 
rabbit serum by the addition of immune complexes, followed by incubation at 370C for 1 hr 
and removal of the precipitate by centrifugation (2). Rabbit IgG, obtained from high-titer 
antisera to bovine serum albumin (BSA), was purified by ion-exchange chromatography (4). 
In order to activate serum,  and thus generate the chemotactic factor, I00/zg antibody N, 
with antigen at equivalence,  was mixed with each 0.1 ml of fresh serum. The ehemotactie 
factor was also generated by addition of zymosan to fresh rabbit serum (2). Unless otherwise 
indicated, "activated serum" refers to serum treated with an immune complex. 
Isolation  of C  t (5, 6, 7) ~.--The partially  purified nonactivated chemotactic factor, C'(5, 6, 7), 
was obtained by eluting rabbit euglobulin from triethylaminoethylcellulose  (TEA_E-cellulose). 
The Cr(5, 6, 7) was then activated by incubation with sensitized erythrocyte stromata con- 
talning the first four reacting components  of complement.  These procedures have been de- 
scribed in  detail in  earlier reports  (2,  3).  Ct(5,  6,  7), not interacted with  the  first four 
complement  components  and  therefore  not  chemotactically active, is referred  to  as  the 
"nonactivated TEAE fraction." The material which has been reacted so as to make it chemo- 
tactically active [rich in Ct(5, 6, 7)~] is termed the "activated TEAE fraction." 
1  The "Principles of Laboratory Animal Care" as promulgated by the National Society for 
Medical Research were observed during this study. Animal facilities were provided by the 
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Phosphonate Esters.--The p-ultrophenyl ethyl phosphonates with the structure 
R--~<~  C'I~  N0~  © 
in which R  is either a  phenylalkyl, alkyl, or chloroalkyl group, were the same as used pre- 
viously (6). In what follows,  the phosphonates will be named only according to the R  group, 
the presence of the p-ultrophenoxy and ethoxy groups being implied. The phosphonates were 
dissolved in acetone and then appropriately diluted to a final concentration of 0.5% acetone. 
This concentration of  acetone had previously  been determined not  to  interfere with  the 
chemotactic behavior of the leukocyte (6). 
Other Esters.--The simple carboxylic acid esters, phosphate esters, and amino acid esters 
employed here were the same as used previously (7). They were dissolved in medium 199. 
In addition to these esters, additional amino acid esters were also employed as well as N-acetyl 
,rn{,o adds.  These were alt obtained from Mann Research Laboratories  (IN. Y.)  and used 
in the same way as the others. 
Dea~vation of Leukovytes.--In  most  "deactivation" experiments leukocytes were incu- 
bated at room temperature for 30 rain with a 30% (v/v) concentration of chemotactic factor. 
The final leukocyte suspension was 2  X  106 cells/ml. The source of the chemotactic factor, 
C'(5, 6,  7)s, was either activated homologous serum or the activated TEAE fraction. After 
incubation at room temperature for 30 rain, the leukocytes were then diluted 10-fold  in me- 
dium 199, centrifuged, and resuspended in 10% fresh rabbit serum for testing of their chemo- 
tactic responsiveness in chambers. In some experiments, the concentration of chemotactic 
factor and duration of incubation were varied as indicated. 
The inhibition of the ceil responsiveness was calculated as one,  minus the ratio of cell 
counts of responding cells that had been treated with deactivating factor to the number of 
responding cells that were not pretreated in this manner, all multiplied by 100. 
Protection against De.acHvation.--in all  deactivation experiments in  which phosphonate 
esters or amino acid, earboxylie add, or phosphate esters were used, the source of chemotactic 
factor was the ad~vated TEAE fraxtion  (see above), in order to obviate the problem of the 
hydrolysis of the phosphonate compounds or esters by enzymes present in rabbit serum (8). 
In addition, the final suspending medium for the polymorphounclear leukocytes was 0.5% 
ovalbumin (6). The source of chemotactic factor (present in the lower compartment of cham- 
bers) was rabbit serum activated by incubation with immune complexes.  In those experi- 
ments in which the protective effects of the amino acid esters against deactivation were studied, 
one volume of cells (6 X  106/ml) was added to one volume of ester and one volume of chemo- 
tactic factor. The final concentration of the ester is expressed in the tables. For controls, cell 
suspensions were incubated with the esters alone and with chemotactic factor alone. Reaction 
volumes were always kept constant. When the phosphonate esters were tested for their ability 
to prevent deactivation of polymorphonuclear leukocytes by the chemotactic factor,  they 
were used in concentrations sufficiently low so that no cell-dependent inhibition (see intro- 
duction) was evident. The ability of certain compounds to protect neutrophils from deactiva- 
tion caused by contact with the chemotactic factor was calculated as the ratio of the inhibi- 
tion of chemotactic responsiveness (deactivation) in the absence of phosphonates or amino 
acid esters, minus the inhibition of cell responsiveness in the presence of the protective agent, 
to the inhibition of chemotactic responsiveness in the absence of the protecting substance. 
This ratio, multiplied by 100, was expressed as "per cent protection." For example, if cells 
treated with chemotactic factor and then assayed in chemotactic chambers bad 40% of the 
chemotactic response of  untreated cells  (that is,  they were  inhibited 60°/v),  whereas ceils 696  DEACTIVATION  OP  RABBIT  NEUTROPHILS 
treated with chemotactic factor in the presence of phosphonate  gave a 70% response com- 
paxed with normal untreated  cells, the degree of protection from deactivation effected by the 
phosphonate would be 100[(60-30)/60] or 50% protection. 
R.ESULTS 
Deactivation  of Polymorphonuclear  Leukocytes  by  Activated  Serum.--When 
polymorphonuclear leukocytes were incubated for 30 rnin at room temperature 
with activated rabbit serum,  the ceils were no longer able to respond chemo- 
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FIO.  1. Comparison  of  leukocyte-deactivating  capacity  and  chemotactic  activity  of 
rabbit serum treated  with immune complexes. 
tactically,  that  is,  they were  "deactivated."  The  degree  of deactivation  was 
found to be a function of the concentration of activated serum:  The larger the 
amount of serum employed, the greater was the deactivation (Fig. 1).  Contact 
of cells for 30 mln with 40% serum caused a 90% inactivation of polymorpho- 
nuclear leukocytes. 
The treated serum was also tested for its chemotactic activity using untreated 
cells from the  same batch.  The  chemotactic activity  of the  activated  serum 
was directly proportional to its concentration (Fig.  1).  The curves for change 
of  chemotactic  activity  and  leukocyte-deactivating  activity  with  change  of 
concentration of the same treated serum were closely parallel. 
Deactivation  of  Polymorphonuclear  Leukocytes  by  Serum  as  a  Function 
of Time.--The  ability of the same activated  serum used  in the above experi- PETER A. WAR/)  AND  ELMER  L. BECKER  697 
ment to cause deactivation of polymorphonuclear leukocytes was studied as a 
function of the duration of contact with cells.  Deactivation of leukocytes was 
directly proportional to the duration of contact between cells and treated serum 
(Fig. 2). The curve of deactivation was linear during the first 30 min and then 
slowly leveled off. By 60 min all leukocytes had lost their chemotactic respon- 
siveness. In this experiment, control cells were incubated for similar intervals 
with untreated rabbit serum; these cells did not lose their ability to respond 
to the chemotactic factor. 
Ability of Partly Purified Ckemotactic Factor to Deactivate Leukocytes.--Since 
it was considered likely that deactivation of polymorphonuclear leukocytes by 
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FIG. 2. Leukocyte-deactivating capacity of  rabbit  serum treated  with  immune com- 
plexes as a function of duration of incubation. 
activated serum was due to the presence of the chemotactic factor, partially 
purified C'(5, 6, 7), was used in experiments similar to those described above. 
The activated TEAE fraction, rich in the chemotactic factor, deactivated poly- 
morphonuclear leukocytes to an extent proportional to the concentration of 
chemotactic factor, and the curve of deactivation paralleled the chemotactic 
activity  (Fig.  3).  In  contrast,  a  fraction of nonactivated rabbit  euglobulin~ 
rich in C'(5, 6, 7), which was not chemotactically active, was incapable of de- 
activating leukocytes. 
The degree of deactivation of leukocytes by the activated TEAE fraction 
also increased with duration of contact with the leukocytes (Fig. 4). The simi- 
larity in deactivating capacity and chemotactic activity of treated serum and 
the party purified C'(5, 6, 7),, and the fact that  the substances responsible 
for these two activities eluted from TEAE-cellulose under the same conditions 698  DEACTIVATION  OF RABBIT NEUTROPHILS 
are strong evidence that these activities are in fact biologic properties of the 
same substance. 
Failure  to Generate Deactivating Factor in C'6-Deficient Serum.--The  com- 
plement-associated chemotactic factor requires C'6 for its generation (2). The 
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FIG. 4.  Leukocyte-deactivating capacity of preparation  rich in  C'(5,6,7)a,  as  a  function 
of duration of contact with cells. 
addition of zymosan or immune complexes to rabbit serum genetically deficient 
in C'6  ~ failed to result in appearance of the chemotactic factor (2). This knowl- 
edge was applied in attempts to generate the leukocyte-deactivating factor in 
2 C~6_deficient rabbit  serum was  kindly supplied  by Dr.  Klaus  Rother,  Department  of 
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C'6-suflicient  (normal)  and  C'6-deficient rabbit  serum.  The  defective  serum 
was found to be very poor in its ability to generate the deactivating activity 
(Table I), indicating that C'6 is required for the generation of the deactivating 
factor as well as the chemotactic factor. 
Physical-Chemical  Ckaracteristics  of Leukocyte-Deactivating  Factor.--In order 
to obtain  additional  information on  the  relation of  the  deactivating  factor 
to the  chemotactic factor,  serum  was activated  by incubation  with  immune 
complexes and then subjected to heating and dialysis. The effects of such treat- 
ment on chemotactic and deactivating abilities were then compared. Heating 
serum at 56°C for 1 hr caused only a 9 % reduction in chemotactic activity and 
TABLE I 
Experiments A and B: Requirement  for C'6 in the Generation of Leukocyte-Deactivating Factor 
Leukocyte- 
Experiment  Treatment of cells*  deactivating 
eapadty~ 
A 
B 
Normal serum 
Normal serum activated with immune predpitate§ 
C'6-deficient serum activated with immune precipitate 
Normal serum 
Normal serum treated with zymosan[[ 
C'6-deficient  serum treated  with zymosan 
0 
95 
31 
0 
84 
11 
* 0.3 ml serum plus  1.5  X  l0  s PMN'S in a total volume of 1.0 ml incubated  at room 
temperature  for 20 rain. 
~; Expressed as per cent reduction  of chemotactic responsiveness of cells. 
§ 0.1 ml serum plus 100 ~gN antibody with antigen added at equivalence, in a final volume 
of 1.0 ml. 
l] 0.1 ml serum plus 10 mg zymosan in a final volume of 1.0 ml. 
no loss of deactivating capacity (Table II). Similarly, dialysis had little effect 
on these two activities.  These data on stability of the chemotactic factor and 
the leukocyte-deactivating factor,  taken with  the requirement  for C'6 in the 
generation of both factors and the fact that both substances behave similarly 
in ion-exchange chromatography,  indicate  that  the  two factors  are  probably 
identical. 
Ability of Phosphonate  Esters to Protect against  Deactivation.--The  evidence 
just  described makes it very likely that  the action of the chemotactic factor 
on the leukocyte is responsible for deactivation.  Since the phosphonate esters 
prevent  the  chemotactic  action  of  C'(5,  6,  7)~  on leukocytes,  we  tested  the 
phosphonates for their ability to prevent deactivation by the same factor. The 
results of such experiments, performed as described in the section on Materials 
and Methods, are seen in Table III and Fig. 5. In all experiments,  the concen- 7OO  DEACTIVATION  OF  RABBIT  NEUTROPHILS 
TABLE  II 
Similarity in Properties of ~ke Chemotactic Factor and Leukocyte-Deactivating 
Factor 
Serum 
Normal 
Activated* 
Activated 
Activated 
Treatment of serum 
None 
None 
560C,  1 hr 
Dialyzed in medium 199, 4hr 
Effect of treatment 
of serum on  I 
chemotactlc activity 
(% activity):~ 
0 
100 
91 
100 
Leukocyte- 
deactivating 
capacity of serum§ 
(%) 
4 
73 
77 
80 
* Activated by incubation with immune complexes. See details in Materials and Methods 
10% treated serum used in testing for chemotactic activity. 
§ Expressed  as per cent reduction of ehemotactic responsiveness of cells.  PMN's,  2  X 
106, were incubated with 0.30 ml serum in final volume of 1.0 ml at room temperature for 
30 rain, then washed and resuspended in 10% normal serum for testing. 
TABLE  IH 
Ability  of Phosplwnate  Esters  to  Prote~t Polymorplumu~lear Leukacytes from  Deacti~atCon 
by Chemotacti~ Factor 
Treatment of cells  Chemotaxis 
Phosphonates used  Chemotactic  No. of cells 
(chloroalkyl series*)  factor  responding  Inhibition  Protection 
3-chloropropyl 
3-chloropropyl 
4-¢hlorobutyl 
4-chlorobutyl 
5-chloropentyl 
5-chloropentyl 
6-chlorohexyl 
6-chlorohexyl 
Controls 
None 
None 
+ 
+ 
m 
+ 
m 
+ 
+ 
101 
85 
114 
119 
108 
115 
105 
65 
108 
54 
% 
6 
21 
2 
40 
5O 
% 
58 
100 
100 
20 
* Final concentration at  1 X  10  -4 ~r. Leukocytes were incubated with or without chemo- 
tactic factor ~n the presence or absence of phosphonate esters for 30 rain at room temperature. 
They were then washed, resuspended in 10% normal rabbit serum, and tested for chemotactic 
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tration of phosphonates was kept below that necessary to give cell-dependent 
inhibition. 
Table III shows the results obtained with one of the three homologous series 
of phosphonates tested, the chloroalkyl phosphonates.  These results are illus- 
trative  of  those  generally  obtained.  Incubation  of  the  leukocytes  with 
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FIG.  5.  Comparison of inhibition in chemotactic responsiveness of leukocytes (chemotactic 
factor-dependent inhibition) and protection against deactivation caused by cell contact with 
chemotactic factor, for three different classes of phosphonates. 
the chemotactic factor alone led to a 50 % decrease of chemotactic responsive- 
hess;  that is, they were 50% deactivated. Incubation of the leukocytes with 
the phosphonates alone was without significant effect in every instance. When 
the leukocytes were incubated with the chemotactic factor in the presence of 
the chlorobutyl,  chloropentyl, or chlorohexyl phosphonate, however, there was 
0, 0, and 40% inhibition of chemotaxis, respectively. In other words, depending 
on  the phosphonate  used, 20-100 % protection  against deactivation  was achieved. 
In  Fig.  5,  the  per  cent  protection  from  deactivation  given  by  each TABLE IV 
Ability  of  Various  Esters  and  Acetyl  Amino  Acids  to  Protect  Leukocyte.  from  Deact£~atdon 
by  C'(S,  6,  7), 
Experiment 
A 
B 
Chemao- 
Esters  tactic 
(~ concentration)  factor 
No. of cells  Inhibition Protection  responding 
%  % 
Triacetin (8 X  10  -s)  --  135  0 
"  (8 X  10  -s)  +  28  79  0 
Ethyl acetate (8 X  10  -s)  --  159  0 
"  "  (8 X  10  -s)  q-  32  76  4 
Butyl acetate (8 X  10  -s)  --  137  0 
....  (8 X  10  -s)  +  38  71  0 
Acetyl phosphate (5 X  10  -s)  --  134  0 
"  "  (5 X  10  -s)  +  57  57  23 
Acetylcholine (1 X  10  -2)  --  139  0 
"  (1 X  10  ~)  +  31  76  0 
TAMe*  (5 X  10  -s)  --  136  0 
"  (5 X  10  -s)  +  43  68  8 
Acetyl-L-tyrosine ethyl ester (5 X  10  -s)  --  113  14 
"  "  "  "  (5 X  10  -s)  +  88  33  56 
None  --  132 
"  +  35  74 
Acetyl-L-tyrosine ethyl ester (1 X  10  -s)  --  132  0 
"  "  "  "  (1 X  10  -s)  +  89  34  50 
Acetyl-r.-phenylalanine ethyl ester  --  128  4 
(1 X  10-37 
Acetyl-I~phenylalanine ethyl ester  q-  98  27  61 
(1  X  10  -s) 
Acetyl-~-tryptophan ethyl ester  --  1~8  0 
(1 X  t0  -3) 
Acetyl-~-tryptophan ethyl ester  +  118  12  84 
(1 X  t0-~ 
Acetyl-r.-tyrosine (1 X  10  -s)  --  128  4 
....  (1 X  10  -s)  +  110  18  74 
Acetyl-L-tryptophan (1 X  10  -s) 
....  (1 X  10  -s)  + 
Acetyl-Dz-phenylalanine (1 X  10  -s) 
"  "  (1 X  10  -s)  + 
140  0 
119  11  86 
t 
132  0  [ 
55  59  14 
* Tosyl-L-arginlne methyl ester. 
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703 
Experiment 
Chemo-  Esters 
(~¢ concentra~on)  tactic  factor 
Benzoyl-L-arginine  methyl ester 
(1  X  10  -8) 
Benzoyl-L-arginine methyl ester 
(1 X  10  -8)  +  49  63  9 
Acetyl-L-glyeine  (1 X 10  -8)  --  118  11 
....  (1  ×  to  -8)  +  49  63  9 
Acetyl-rAeucine (1 X 10  -8)  --  104  22 
"  "  (1 X 10  -8)  +  41  70  0 
Acetyl-aLlo-L-isoleucine  (1 X 10  -8)  --  133  0 
"  "  "  (1 X  10  -8)  +  39  71  0 
None  --  134  -- 
"  +  42  69 
No. of cells  Inhibition Protection  responding 
%  % 
136  0 
phosphonate is plotted against the number of carbon atoms in the alkyl chain 
of the chloroalkyl phosphonates, the alkyl phosphonates, and the phenylalkyl 
phosphonates. The "protection profiles" were all obtained at a 1.0 X  10-~ con- 
centration of the phosphonates. The ability of the different members of a given 
homologous series  of  phosphonates  to  give  protection  against  deactivation 
was compared only in experiments run at the same time with the same batch 
of cells and partially purified chemotactic factor. In the same figure the inhibi- 
tion profiles for chemotactic-depcndent inhibition given by the same phospho- 
nates are also plotted. These are taken from Fig. 6 of reference 6. 
It is evident from Fig. 5 that the protection profiles given by the chloroalkyl 
phosphonates, the alkyl phosphonates, and the phenylalkyl phosphonates are 
essentially the same as  the "inhibition profiles" obtained when the identical 
three series of phosphonates were tested for their ability to give chemotactic 
factor-dependent inhibition.  This  implies  that  the  "activatable  esterase"  is 
involved not only in chemotaxis but also in deactivation. 
Ability  of  Aromatic  Amino  Acid  Derivatives  to  Protect  Polymorphonuclear 
Leukocytes .from  Deactivation.--If,  as  just  demonstrated,  phosphonate  esters 
prevent deactivation by blocking the action of the activatable esterase, sub- 
strates  or  competitive inhibitors  of  this  esterase might  also  protect  against 
deactivation by reversibly interfering with the action of the enzyme. Therefore, 
carboxylic acid esters, amino acid esters, and phosphate esters were tested for 
their ability to prevent deactivation. 7O4  DEACTIVATION  O]~ RABBIT  NEUTROPHILS 
The various esters were incubated with the leukocytes and chemotactic factor 
as described in the section on Materials and Methods. The results are seen in 
Table  IV.  The  simple  acetate  esters tested,  namely triacetin,  ethyl acetate, 
acetyl phosphate,  etc., had previously been shown to prevent cell-dependent 
inhibition by the  phosphonates and  also to inhibit chemotaxis by interacting 
with the activated esterase (7). They were unable to protect completely against 
deactivation  induced by the  chemotactic factor  (Table IV,  Experiment  A). 
(The 23 % protection obtained with acetyl phosphate was not obtained in other 
experiments.) In contrast, aromatic amino acid esters such as acetyl-~-tyrosine 
ethyl ester and  acetylated aromatic  amino  acids were distinctly  effective in 
protecting against deactivation  (Table IV,  Experiment  B). Acetyl-L-tyrosine 
ethyl ester had previously been shown to be completely ineffective in protecting 
against ceU-dependent inhibition (7). The protection against deactivation given 
by the aromatic amino acid derivatives is  specific;  other nonaromatic  amino 
acid esters, namely, tosyl-L-arginine  methyl ester (TAMe) (Table IV, Experi- 
ment A), benzoyl-x.-arginine methyl ester, and nonaromafic acetylated amino 
acids such as acetyl-L-glycine, acetyl-L-leucine, or acetyl-allo-r-isoleucine  (Table 
IV, Experiment B), were not active. 
Direct Inhibition of Chemotaxis  by  Various Amino Acid Derivatives.--If  the 
aromatic amino acid derivatives prevent deactivation by interfering with the ac- 
tion of the activatable esterase and if, as already shown, this enzyme is required 
in chemotaxis, then one would expect that the same aromatic amino acid deriva- 
tives would also prevent chemotaxis. To test this inference,  the various amino 
acid derivatives were examined for their effect on chemotaxis when added di- 
rectly to the upper  compartment  of the chamber  containing  the leukocytes. 
Ethyl acetate, acetoxyacetic acid,  and acetyl phosphate, which interfere with 
the "activated esterase" but do not inhibit the activatable esterase (7),  were 
also tested. The results of the experiments, employing a final concentration of 
the amino acid compound of 2 X  10-~, are given in Table V. Acetyl-L-tyrosine 
ethyl ester and acetyl-r.-tryptophan ethyl ester were highly inhibitory, as were 
acetyl-L-phenylalanine ethyl ester and acetyl-DL-phenylalanine  (Table V, Exper- 
iment A).  On  the  other hand,  acetyl isoleucine  and acetyl glycine  were not 
inhibitory (Table V, Experiment A), while glycine ethyl ester, tosyl-L-arginine 
methyl ester,  and benzoyl arginine methyl ester gave 12 % or less inhibition 
(Table V,  Experiment  B).  In other experiments  these latter  compounds did 
give higher  inhibition  than  seen here.  In  general,  however, the nonaromatic 
derivatives were distinctly less inhibitory than the aromatic ones. Ethyl acetate, 
acetoxyacetic acid,  and  acetyl phosphate inhibited,  as was expected, due to 
their ability to interfere with the activated esterase (7). Thus, three groups of 
compounds have so far been found to more or less specifically  prevent chemo- 
taxis: simple acetates, which inhibit the activated esterase (7); aromatic amino 
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TABLE V 
Experiments A  and B: Direct Inhibition of Chemotaxis by AromaHc Amino Acid Compounds 
Experiment  Material  added to cell  suspension  No. of cells  Inhibition  responding* 
A~ 
B 
Acetyl-Lotyrosine ethyl ester 
Acetyl-L-tryptophan  ethyl ester 
Acetyl-I.phenylalanine  ethyl ester 
Acetyl-DL-phenylalanine 
Aeetyl isoleucine 
Acetyl glycine 
None (positive control) 
None (negative control) 
Tosyl-L-arginine methyl ester 
Benzoyl-L-arginine methyl ester 
13 
8 
32 
19 
57 
59 
38 
46 
108 
96 
100 
98 
0 
176 
195 
Glycine ethyl ester 
Acetyl-L-leucine 
Acetyl-bglycine 
Ethyl acetate 
Acetoxyacetic  acid 
Acetyl phosphate 
None (positive control) 
None (negative control) 
224 
180 
100 
55 
95 
105 
200 
0 
% 
87 
92 
68 
81 
43 
41 
62 
54 
12 
2 
0 
10 
50 
72 
72 
49 
* All chambers except the negative control contained 10~o activated rabbit serum in the 
bottom compartment. 
~: Compounds  were added at a  concentration of 2  X  10  -3 M. In Experiment A studies 
were done in duplicate. 
which inhibits neither and whose mechanism of inhibition of chemotaxis is still 
unknown  (7). 
DISCUSSION 
Sufficiently prolonged  contact  of  the  polymorphonuclear  leukocytes  with 
preparations containing the chemotactic factor, C'(5, 6, 7)a, leads to a complete 
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C'(5, 6, 7)s. The deactivating factor in serum or partially purified preparations 
and the chemotactic factor are .~imilar in that they require C'6 for generation 
(Table I), both  elute  similarly in  ion-exchange chromatography,  and  there 
is a relationship between deactivation and chemotaxis as revealed by the effects 
of phosphonate esters and aromatic amino acid derivatives. The phosphonate 
esters prevent deactivation and also prevent chemotaxis. Moreover, the profiles 
of protection against  deactivation given by the  three series  of phosphonate 
esters were essentially the same as those found in the chemotactic factor--de- 
pendent  inhibition  (Fig.  5).  This  indicates  that  the  same  enzyme,  the 
"activatable esterase," is involved in both processes, making it most likely that, 
in fact, C'(5, 6, 7), is responsible for deactivation as well as chemotaxis. 
There are several possible mechanisms to explain deactivation of neutrophils 
by the complement-associated chemotactic factor. One possibility is a more or 
less irreversible saturation of the hypothetical cell receptors by the chemotactic 
factor. Although phosphonate esters and aromatic amino acid derivatives pre- 
vent deactivation, it is improbable that they do so by interfering with the com- 
bination of the chemotactic factor and the putative receptors.  Another pos- 
sibility is that the  activation of  the  proesterase results in an active enzyme 
that is exceedingly labile, either intrinsically or because of a natural inhibitor. 
This explanation is analogous to that offered by Mongar and Schild (9) for the 
antigen-induced desensitization of acute allergic responses. It is also possible 
that activation of the proesterase is required for the oriented movement of the 
cell induced by the chemotactic factor and that activation of all the proesterase 
prevents  such  oriented  response  to  chemotactic  factor.  Finally,  it  is  also 
possible that deactivation is nothing more than the utilization of a  substrate 
or cofactor that is required for the chemotactic response of the neutrophil and 
that is present in very limited concentration on the cell. The data in this paper 
do not permit a selection of any one of these possibilities. 
The manner in which the phosphonates prevent deactivation not only indi- 
cates that the  activatable esterase is involved, but also throws light on the 
manner in which this esterase is activated. The phosphonates "protect" against, 
that is, prevent deactivation by irreversibly inhibiting the activatable esterase 
following its activation. Such protected cells are still able to give a chemotactic 
response to C'(5, 6, 7)s, however, implying that there is still activatable esterase 
available within or on the cell in precursor form. Thus, in protecting against 
deactivation, the phosphonates prevent further activation of the activatable 
esterase. This implies that the enzymatic activity of the activatable esterase 
is required for the further activation of this enzyme. In other words, the activa- 
tion of this esterase is, at least in part~  an autocatalytic process.  This is pre- 
cisely analogous to the activation of C'I to C'la by an antigen-antibody com- 
plex, also a process at least partly autocatalytic (10). 
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the phosphonate esters be used at a concentration low enough not to affect the 
"activated esterase." It was therefore impossible to tell from these experiments 
whether  the  activated  esterase was  involved in  deactivation. Acetate  esters 
previously shown to prevent the action of the activated esterase did not prevent 
deactivation,  however,  indicating  that  deactivation  can  occur  without  the 
action of this second enzyme. This means that deactivation involves only part 
of the biochemical mechanism of chemotaxis. A further implication is that in 
chemotaxis the activated esterase either does not act in the same biochemical 
sequence as the activatable esterase, or if it does, its action is later than that 
of this enzyme. 
The only other substances besides the phosphonates found to prevent deac- 
tivation were aromatic amino acid derivatives (Table IV). Nonaromatic amino 
acid derivatives of basic amino acids such as tosyl-v.-arginlne methyl  ester or 
benzoyl-v.-arginine methyl ester, or acetylated nonaromatic amino acids such 
as acetyl-L-glycine or acetyl-L-leucine, were more or less inactive in this regard. 
The same aromatic amino acids that protect against deactivation also inhibit 
chemotaxis when added~ with the leukocytes, to the upper compartment of the 
chamber (Table V). 
One possible explanation for the ability of aromatic amino acid derivatives 
to protect against deactivation and to inhibit chemotaxis is that an enzyme 
that has a particular affinity for aromatic amino acids is required in both proc- 
esses.  As  shown,  the  activatable esterase is involved in both chemotaxis and 
deactivation. It is therefore plausible to suggest that the activatable esterase 
is an enzyme with a particular affinity for aromatic amino acid esters and aro- 
matic amino acid derivatives. Although plausibility is no guarantee of truth, 
it can serve as a  guide for future work. 
SUMMARY 
As shown previously, immune complexes engender in rabbit serum a  factor 
capable of inducing chemotaxis of rabbit polymorphonuclear leukocytes. This 
chemotactic factor consists of a  complex of the fifth, sixth, and seventh com- 
ponents of complement. As demonstrated here, the polymorphonuclear leuko- 
cytes incubated with such treated rabbit serum lose their ability to respond 
chemotactically to the chemotactic factor. They are "deactivated." 
The process of "deactivation" is a function of the duration of contact of the 
cells with, and the concentration of, the treated serum. There is a parallelism 
between the time course of deactivation and of chemotaxis, as well as the dose- 
response curves for the two processes. Chemotactic factor purified by isoelectric 
precipitation and ion-exchange chromatography produces deactivation in the 
same manner as the treated serum. The deactivating activity requires, as does 
the chemotactic factor, the sixth component of complement; like the chemo- 
tactic factor,  it  is  heat-stable  and  nondialyzable.  Deactivation is  prevented 708  DEACTIVATION  OF  RABBIT  NEUTROPHILS 
by the same phosphonate esters shown previously to prevent chemotaxis by 
the complement-associated chemotactic factor. The profiles of the phosphonates 
in protecting against deactivation are the same as the profiles for the chemo- 
tactic factor-dependent inhibition of chemotaxis. Aromatic amino acid deriva- 
tives prevent both chemotaxis and deactivation. We conclude from this evi- 
dence that the chemotactic factor is able to deactivate or induce chemotaxis 
depending upon experimental conditions. 
The fact that the profiles given by the phosphonates for protection against 
chemotactic  factor-dependent  deactivation  and  for  chemotactic  factor-de- 
pendent inhibition of chemomxis are the same indicates that the "activatable 
esterase" is involved in both processes. Acetate esters such as ethyl acetate 
and others shown previously to prevent chemotaxis by inhibiting the "activated 
esterase" do not prevent deactivation.  This indicates  that  deactivation can 
occur without participation of the latter enzyme, implying that deactivation 
involves only a  part of the biochemical mechanism of chemotaxis. 
The protection against deactivation afforded by aromatic amino acid deriva- 
tives is specific, insofar as nonaromatic amino compounds and simple acetate 
esters have no effect. In addition, as stated, the aromatic amino acid derivatives 
inhibit  deactivation  and  chemotaxis by  the  chemotactic factor.  This  latter 
finding, together with the demonstration of the involvement of the activatable 
esterase  in  both deactivation and  chemotaxis, suggests  that  the activatable 
esterase of the rabbit polymorphonuclear leukocyte is a serine esterase with a 
special affinity for aromatic amino acid derivatives. 
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